Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Stokoe

Showing results (41-50 of 83) with videos related to

Pageof 9
Sort By:
Bioorganic & Medicinal Chemistry Letters|October 24, 2006
Rational design of a nonpeptide general chemical scaffold for reversible inhibition of PDZ domain interactionsNaoaki Fujii, Jose J Haresco, Kathleen A P Novak, et al.
Cancer Cell|May 16, 2006
A dual PI3 kinase/mTOR inhibitor reveals emergent efficacy in gliomaQi-Wen Fan, Zachary A Knight, David D Goldenberg, et al.
Human Molecular Genetics|October 6, 2005
ZNF217 suppresses cell death associated with chemotherapy and telomere dysfunctionGuiqing Huang, Sheryl Krig, David Kowbel, et al.
Plos One|June 19, 2018
A CRISPR screen identifies MAPK7 as a target for combination with MEK inhibition in KRAS mutant NSCLCNicholas Dompe, Christiaan Klijn, Sara A Watson, et al.
Science Signaling|January 30, 2009
EGFR signals to mTOR through PKC and independently of Akt in gliomaQi-Wen Fan, Christine Cheng, Zachary A Knight, et al.
Cancer Research|October 3, 2008
PIK3CA cooperates with other phosphatidylinositol 3'-kinase pathway mutations to effect oncogenic transformationKatsutoshi Oda, Jennifer Okada, Luika Timmerman, et al.
Cell Cycle (Georgetown, Tex.)|June 28, 2008
Cell cycle-dependent phosphorylation of human CDC5 regulates RNA processingRemo Gräub, Hope Lancero, Anissa Pedersen, et al.
Journal of Neuro-Oncology|September 2, 2008
Signal transduction molecules in gliomas of all gradesRalph P Ermoian, Tania Kaprealian, Kathleen R Lamborn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 15, 2002
Dysregulation of PTEN and protein kinase B is associated with glioma histology and patient survivalRalph P Ermoian, Constance S Furniss, Kathleen R Lamborn, et al.
Molecular Cancer Therapeutics|April 17, 2008
Characterization of structurally distinct, isoform-selective phosphoinositide 3'-kinase inhibitors in combination with radiation in the treatment of glioblastomaJack S Chen, Linda J Zhou, Michal Entin-Meer, et al.
Pageof 9

Showing results (41-50 of 83) with videos related to

Sort By:
Pageof 9
Bioorganic & Medicinal Chemistry Letters|October 24, 2006
Rational design of a nonpeptide general chemical scaffold for reversible inhibition of PDZ domain interactionsNaoaki Fujii, Jose J Haresco, Kathleen A P Novak, et al.
Cancer Cell|May 16, 2006
A dual PI3 kinase/mTOR inhibitor reveals emergent efficacy in gliomaQi-Wen Fan, Zachary A Knight, David D Goldenberg, et al.
Human Molecular Genetics|October 6, 2005
ZNF217 suppresses cell death associated with chemotherapy and telomere dysfunctionGuiqing Huang, Sheryl Krig, David Kowbel, et al.
Plos One|June 19, 2018
A CRISPR screen identifies MAPK7 as a target for combination with MEK inhibition in KRAS mutant NSCLCNicholas Dompe, Christiaan Klijn, Sara A Watson, et al.
Science Signaling|January 30, 2009
EGFR signals to mTOR through PKC and independently of Akt in gliomaQi-Wen Fan, Christine Cheng, Zachary A Knight, et al.
Cancer Research|October 3, 2008
PIK3CA cooperates with other phosphatidylinositol 3'-kinase pathway mutations to effect oncogenic transformationKatsutoshi Oda, Jennifer Okada, Luika Timmerman, et al.
Cell Cycle (Georgetown, Tex.)|June 28, 2008
Cell cycle-dependent phosphorylation of human CDC5 regulates RNA processingRemo Gräub, Hope Lancero, Anissa Pedersen, et al.
Journal of Neuro-Oncology|September 2, 2008
Signal transduction molecules in gliomas of all gradesRalph P Ermoian, Tania Kaprealian, Kathleen R Lamborn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 15, 2002
Dysregulation of PTEN and protein kinase B is associated with glioma histology and patient survivalRalph P Ermoian, Constance S Furniss, Kathleen R Lamborn, et al.
Molecular Cancer Therapeutics|April 17, 2008
Characterization of structurally distinct, isoform-selective phosphoinositide 3'-kinase inhibitors in combination with radiation in the treatment of glioblastomaJack S Chen, Linda J Zhou, Michal Entin-Meer, et al.
Pageof 9